Glenn M. Chertow
Publication Details
-
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Am Heart J. 2005; (5): 820-5
Patients affected by end-stage renal disease (ESRD) demonstrate a very high cardiovascular risk mediated by traditional cardiovascular risk factors as well as abnormal mineral metabolism and a state of chronic inflammation. Sevelamer is a nonabsorbable non-calcium-based hydrogel with potential antiatherosclerotic properties.
Help